Insider: Monahan Joseph Chief Scientific Officer - Aclaris Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 129,724 | 0 | 129,724 |
| Value | $258,150.76 | $0.00 | $258,150.76 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/23/2023 | DDS | 6,000 | Direct | COM | $5.08 | $30,460.20 | 129,724 |
| 08/21/2023 | DDS | 6,000 | Direct | COM | $7.32 | $43,894.80 | 135,724 |
| 06/20/2023 | DDS | 6,000 | Direct | COM | $10.28 | $61,662.60 | 141,724 |
| 03/03/2023 | DDS | 16,037 | Direct | COM | $12.63 | $202,614.67 | 147,724 |
| 03/02/2023 | DDS | 14,800 | Direct | COM | $12.37 | $183,024.20 | 151,261 |
| 02/15/2023 | DDS | 5,000 | Direct | COM | $13.06 | $65,310.50 | 91,386 |
| 12/15/2022 | DDS | 5,000 | Direct | COM | $15.88 | $79,411.50 | 96,386 |
| 10/17/2022 | DDS | 5,000 | Direct | COM | $15.98 | $79,907.50 | 101,386 |
| 04/18/2022 | DDS | 30,000 | Direct | COM | $16.28 | $488,298.00 | 106,386 |
| 03/10/2022 | DDS | 27,165 | Direct | COM | $15.71 | $426,802.90 | 136,386 |
| 02/09/2022 | DDS | 383 | Direct | COM | $12.68 | $4,857.13 | 87,301 |
| 06/02/2021 | DDS | 18,240 | Direct | COM | $21.50 | $392,231.14 | 88,892 |
| 06/02/2021 | DDS | 3,550 | Direct | COM | $22.31 | $79,205.47 | 85,342 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research